Tirzepatide emerges a groundbreaking treatment agent for individuals struggling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://adrianalqsw941321.blogginaway.com/41299928/tirzepatide-a-new-frontier-in-diabetes-treatment